Immortalized Cell Line Market – Global Industry Growth, Trends, and Forecast (2023-2029)

The Global Immortalized Cell Line Market size was valued at USD 2.8 Bn in 2022 and is expected to reach USD 4.4 Bn by 2029, at a CAGR of 6.5%.
Immortalized Cell Line Market Overview
Immortalized cells refer to cells that have surpassed the normal cell cycle division and continue to divide repeatedly. These cells are capable of prolonged growth and can be created either by manipulating cells artificially or through the development of tumorous cells. They are used to produce large quantities of identical cells for an indefinite period and are widely utilized in various research applications, including tissue engineering, vaccine production, and cell therapies.

The Immortalized Cell Line Market is experiencing rapid growth due to the increasing demand for advanced techniques such as vaccine production, cell transplantation, and drug transport. This growth is further fueled by the high and continuous demand for cells and the cost-effectiveness of immortalized cells compared to primary cells. For instance, in 2022, approximately 88,901 patients were on the waiting list for kidney transplants, highlighting the need for efficient and effective cell-based therapies.

However, the cost of advanced technology is expected to hinder the market's growth in the forecasted period. Despite this, the Immortalized Cell Line Market is set to continue its expansion due to the increasing need for cell-based therapies in a wide range of research applications.To know about the Research Methodology :- Request Free Sample Report
The Immortalized cell line Market Scope and Methodology:
The scope of the Immortalized Cells market analysis is to provide a comprehensive evaluation of the industry, covering various aspects such as resolution, distribution channel, application, and region. The report aims to analyze the market growth rate, market size, market drivers, trends, challenges, and opportunities. Additionally, the report provides a forecast of the market trends for the period of 2022 to 2029, taking into account the impact of COVID-19 on the market. The bottom-up approach was used to estimate the Immortalized Cell Line Market size.

The methodology used for the market analysis involves primary and secondary research, primary research includes interviews with leaders, industry experts, and market key players. The secondary research involves a comprehensive study of industry reports, company annual reports, government sites, online information gathering, and databases.
SWOT analysis is performed for a strategic planning and strategic management technique used to help the organization identify Strengths, Weaknesses, Opportunities, and Threats related to business competition or project planning. Porter’s analysis is conducted to analyze an organization's strengths and weaknesses and to identify critical factors that affect your profitability. PESTALS analysis strategic framework that is used to evaluate the environment in which an organization operates.
Immortalized cell line Market Dynamics:
Advancements in gene editing and synthetic biology techniques have increased the demand for immortalized cell lines for research and development purposes. The growing prevalence of chronic diseases, such as cancer, diabetes, and heart disease, has led to an increased demand for immortalized cell lines for drug discovery and development as immortalized cell provides continue production of the same type of cells.

Rising investment in research and development activities in biotechnology and pharmaceutical companies is driving the demand for Immortalized Cell Line Market for various applications and as a result of applications, the market is predicted to rise within the forecast period.

Increasing demand for personalized medicine and regenerative medicine is the key driver for the Immortalized Cell Line Market as the market of personalized medicine is growing with a CAGR of 6.90%. Researchers discovered the use of CRISPR gene-editing technology to create personalized cancer vaccines using patients’ own immune cells that have been immortalized to produce large quantities of identical cells for therapy.
Ethical and legal concerns regarding the use of immortalized cell lines are expected to hinder market growth as they are taken from human donors, and working with them has been obtained legally, ethically, and with due considering the well-being, and privacy of the donor. The lack of skilled professionals, limited access to advanced technologies, and infrastructure may limit the adoption of immortalized cell lines in emerging economies.

Safety concerns regarding the use of immortalized cell lines in clinical trials and therapies, as the processes involved hazards such as UV lights, working with endogenous pathogens, and infecting agents may restrain the Immortalized Cell Line Market growth within the forecast period.

The risk of contamination and genetic drift in cell lines may contaminate other cell lines, resulting in loss of costly reagents, and samples. Controversy about the Covid-19 vaccines and led to calls for alternative sources, despite the fact that these cell lines have been extensively tested and researched over time.

Immortalized Cell Line Market Opportunities:

Increasing adoption of 3D cell culture technology is expected to create new growth opportunities for the immortalized cell lines market as the market is growing with a CAGR of 17.2% and is valued at USD 1.6 Bn. in 2021. Growing demand for cell-based assays and high-throughput screening for drug discovery is expected to create opportunities. Growing demand for biologics and biosimilars is expected to drive the demand for immortalized cell lines for manufacturing and production purposes.

Market Challenges:

The lack of standardization and quality control in the production and characterization of immortalized cell lines may limit their adoption and also high development and maintenance costs associated with the production of immortalized cell lines may limit their adoption in emerging economies. Issues related to intellectual property rights and patent infringement may challenge the Immortalized Cell Line Market’s growth. The problem with the lack of transparency and awareness of the use of immortalized cell lines may lead to public mistrust and limit market growth.

For a more in-depth analysis of the covid-19 pandemic’s impact on the market, restraints, opportunities, and drivers for individual markets to gain insights of the market refer maximize market research report on Immortalized cell line market.
Immortalized cell line Market Segments Analysis:
Based on the type of cells, the Immortalized Cell Line Market can be segmented into human cells and animal cells. The human cells segment is expected to hold the largest share of the market due to the high demand for human cells in research and clinical applications. Human cells are selected due to their similarity to human physiology, which helps in a better understanding of human diseases and treatments. Researchers have developed immortalized cell lines for heart cells, which could potentially be used to treat heart disease and repair damaged cardiac tissue.

Based on the application, the Immortalized Cell Line industry is segmented into research, drug discovery and development, regenerative medicine, vaccine production, and others. The research segment is expected to hold the largest share of the market due to the high demand for immortalized cells in basic research and drug discovery. Immortalized cells are used in research to study cell function, protein expression, gene regulation, and other cellular processes, this segment is predicted to hold the largest market share within the forecast period.

Based on the end-users, the market can be segmented into biotechnology and pharmaceutical companies, and research institutes. The biotechnology and pharmaceutical companies segment is expected to hold the largest share of the Immortalized Cell Line Market due to the high demand for immortalized cells in drug discovery and development. Immortalized cells are used to test drug efficacy, toxicity, and pharmacokinetics. The drug discovery market size was valued at USD 55.72 Bn. in 2022 and is predicted to provide emerging opportunities for the market players in the immortalized cells market.

The remaining segment of the immortalized cells market is elaborated on in the report with prior examples and statistical data to provide in-depth information.
Immortalized Cell Line Market Regional Insights:
Regional analysis of the Immortalized Cell Line Market provides an overview of the market performance in different regions. Information is elaborated in a way to identify the key factors that are driving the growth of the market in each region, as well as the challenges and opportunities that exist. The Immortalized Cells market can be segmented into several regions, including North America, Europe, Asia Pacific, The Middle East and Africa, and South America.
North America and Europe are the largest markets for Immortalized Cells line, owing to the presence of major market players, increasing research and development activities, a growing demand for advanced treatments, an increase in the occurrence of cancer, the presence of well-established biotechnology and pharmaceutical industry, growing awareness of immortalized cell lines, and strong research funding.

The Asia Pacific Immortalized Cell Line Market is expected to witness the highest growth rate during the forecast period, due to the rising awareness of chronic diseases, increasing healthcare expenditure, and a large population base. The market in this region is also driven by government initiatives to improve healthcare infrastructure and increase awareness about advanced treatment.

The report on Immortalized Cell Line Market by MMR provides more in detail information on a study of the market size, market share, growth rate, and future trends in each region, Overall, the regional analysis helps to identify the key growth opportunities and challenges in each region, which can help market players to make informed decisions and develop effective strategies to expand their market presence.
Competitive Landscape:
The competitive landscape of the Immortalized Cell Line Market includes an analysis of the key players operating in the market, their market share, their growth strategies, and their recent developments, mergers, acquisitions, partnerships, and collaborations.

Thermo Fisher Scientific completed its acquisition of PeproTech company on December 30, 2021, for a total cash purchase price of approximately USD 1.85 Bn. Also the cell and gene therapy contract development and manufacturing organization, PCT, in 2021 to expand in the cell and gene therapy field.

Merck KGaA has a net sales of 22 Bn. In 2022 and also Merck announced the launch of its Ultimus Single-Use Process Container Film, designed to provide extreme durability and leak resistance for single-use assemblies used for bioprocessing liquid applications.

Apart from these strategies, companies are also launching new products and expanding their offerings to meet the increasing demand for immortalized cell lines. For example, va-Q-tec and Sartorius are partnering to create a safer, simpler, and more sustainable cold-chain transportation system for active pharmaceutical ingredients (APIs) and bulk drug substances.

As more companies are entering this field, the competition is becoming more intense, and everyone is trying to offer innovative products and strategic partnerships to increase their market share the report covers major aspects according to needs of the users.
Immortalized Cell Line Market Scope: Inquire before buying



Immortalized Cell Line Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2017 to 2022
Market Size in 2022:
US $ 2.8 Bn.


Forecast Period 2023 to 2029 CAGR:
6.5%
Market Size in 2029:
US $ 4.4 Bn.


 Segments Covered:
by Type
1. Human cells
2. Animal cells


by Application
1. Research
2. Drug discovery and development
3. Regenerative medicine
4. Vaccine production
5. Others.


by End-User
1. Biotechnology
2. Pharmaceutical companies
3. Research institutes


by Method
1. Virus Induction
2. EBV Genes
3. SV40 T antigen
4. HPV-16 E6/6 gene
5. Other



Global Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Immortalized Cell Line Market Key Players:
1. Thermo Fisher Scientific Inc.
2. ATCC
3. Lonza Group AG
4. Sartorius AG
5. Merck KGaA
6. Corning Incorporated
7. BioIVT
8. Promocell GmbH
9. ZenBio Inc.
10. Caisson Laboratories Inc.
FAQ's
1] What is the growth rate of the Global Immortalized Cell Line Market?
Ans. The Global Immortalized Cell Line Market is growing at a significant rate of 6.5% over the forecast period.

2] Which region is expected to dominate the Global Immortalized Cell Line Market?
Ans. European region is expected to dominate the market over the forecast period.

3] What is the expected Global Immortalized Cell Line Market size by 2029?
Ans. The market size of the market is expected to reach USD 4.4 Bn by 2029.

4] Who are the top players in the Global Immortalized Cell Line Industry?
Ans. The major key players in the Global market are Thermo Fisher Scientific Inc., ATCC, Lonza Group AG, Sartorius AG, Merck KGaA, Corning Incorporated.

5] Which factors are expected to drive the Global Immortalized Cell Line Market growth by 2029?
Ans. Advancements in gene editing and synthetic biology techniques is expected to drive the market growth over the forecast period (2023-2029).